Lacosamide (Amneal Pharmaceuticals of New York, LLC)
Welcome to the PulseAid listing for the Lacosamide drug offered from Amneal Pharmaceuticals of New York, LLC. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amneal Pharmaceuticals of New York, LLC |
| NON-PROPRIETARY NAME: | Lacosamide |
| SUBSTANCE NAME: | LACOSAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-11-29 |
| END MARKETING DATE: | 0000-00-00 |
Lacosamide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lacosamide from Amneal Pharmaceuticals of New York, LLC |
| LABELER NAME: | Amneal Pharmaceuticals of New York, LLC |
| DEA SCHEDULE: | CV
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2013-11-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65162-912_32fb4b27-d0ee-4fb9-9f4f-f3845999d299 |
| PRODUCT NDC: | 65162-912 |
| APPLICATION NUMBER: | ANDA204839 |
Other LACOSAMIDE Pharmaceutical Manufacturers / Labelers:
